It’s easy to take product safety standards for granted, but The Tylenol Murders Netflix docuseries about what happened around Chicago in 1982 reminds us that fighting with those safety seals is actually a struggle to appreciate. It was 1983 when the Federal Anti-Tampering Act was enacted, according to House Resolution 1544, “to make it a Federal offense to maliciously cause or attempt to cause injury or death to any person, or injury to any business’ reputation, by adulterating a food, drug, cosmetic, hazardous substance or other product.”

As wide and well-intentioned a production practice as drug seals are these days, they’re still not always perfect. In fact, an Indianapolis-based pharmaceutical company has recalled a blood pressure medication for what the FDA calls, “Defective container; inadequately sealed blister packaging.” (This general style of packaging is illustrated in the yellow-background image featured with this story.)

A Tuesday, March 3 report revealed that on February 17, Dublin, OH’s Harvard Drug Group recalled 8,892 cartons of Midodrine Hydrochloride tablets, containing 50 tablets in 5-milligram (mg) doses. Distributed nationwide, the recalled products are distinguishable with the following details:

  • Lot # N02640
  • Exp Date: 08/2027
  • National Drug Code (NDC): 0904-6818-06
  • Distributed by Major Pharmaceuticals

Midodrine hydrochloride, says the National Library of Medicine, can be appropriate for certain cases of hypotension (low blood pressure), stroke, shock, or sepsis.

If you have this drug, call your physician or pharmacy immediately to get advice on how to best proceed.

For daily wellness updates, subscribe to The Healthy by Reader’s Digest newsletter and follow The Healthy on Facebook and Instagram. Keep reading: